search
Back to results

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Primary Purpose

Lung Neoplasms, Non-Small Cell Lung Cancer, Postoperative Complications, Patient Reported Outcome Measures

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ePRO based Remote Symptom Management
Sponsored by
Zhongshan People's Hospital, Guangdong, China
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Lung Neoplasms, Non-Small Cell Lung Cancer focused on measuring Exercise Adherence, ePRO, Remote Monitoring, Postoperative Rehabilitation, Symptom Management

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 18-75 years old Undergoing minimally invasive lung cancer resection Able to use smartphones and complete electronic questionnaires Signed informed consent Exclusion Criteria: ECOG score > 1 Received neoadjuvant therapy Previous lung resection surgery Unable to exercise due to physical limitations Continuous systemic corticosteroid use within 1 month before enrollment Unresolved toxicity above Grade 1 from previous treatments Significant comorbidities or medical history

Sites / Locations

  • No.2 Sunwen East Rd.Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention Group

Control Group

Arm Description

Participants randomized to the intervention group will complete ePRO symptom severity scores on the PSA-Lung questionnaire via the smartphone app on discharge and post-discharge days 3, 7, 14, 21, 28. Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management.

Participants randomized to the control group will complete ePRO symptom severity scores on the PSA-Lung questionnaire via the smartphone app on discharge and post-discharge days 3, 7, 14, 21, 28, without clinician alerts.

Outcomes

Primary Outcome Measures

Rehabilitation exercise adherence rate over 1 month after discharge
Rehabilitation exercise adherence rate over 1 month after discharge, defined as the proportion of patients completing the prescribed outpatient exercise regimen.

Secondary Outcome Measures

Post-discharge pulmonary complication rate
30-day hospital readmission rate
Changes in symptom severity scores from discharge to 30 days
Patient satisfaction scores

Full Information

First Posted
August 6, 2023
Last Updated
August 6, 2023
Sponsor
Zhongshan People's Hospital, Guangdong, China
search

1. Study Identification

Unique Protocol Identification Number
NCT05990946
Brief Title
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
Official Title
A Prospective, Randomized, Controlled Study to Evaluate the Impact of Remote Symptom Management Via Smartphone App Based on Electronic Patient-Reported Outcomes on Rehabilitation Exercise Adherence After Minimally Invasive Surgery in Lung Cancer Patients
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2023 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
March 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Zhongshan People's Hospital, Guangdong, China

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Brief Summary: This randomized controlled trial aims to evaluate whether active remote symptom monitoring and management via a smartphone app utilizing electronic patient-reported outcomes (ePRO) can improve adherence to prescribed outpatient pulmonary rehabilitation exercises among postsurgical lung cancer patients. Eligible patients will use the app for perioperative care and be randomized to an intervention group receiving ePRO-based symptom monitoring with clinician feedback or a control group receiving ePRO without feedback. The primary outcome is rehabilitation exercise adherence rate over 1 month after discharge. If proven effective, the app-enabled remote rehabilitation model can be scaled up to enhance recovery for more postoperative patients.
Detailed Description
Adherence to postoperative pulmonary rehabilitation exercises is crucial but challenging to address in lung cancer patients after hospital discharge. Pain, fatigue, cough and other symptoms may hinder adherence. This study will enroll 224 patients undergoing Video-assisted thoracic surgery (VATS) for lung Cancer. All patients will use a smartphone app for perioperative care and periodic PRO measurement. Before discharge, patients will be randomized 1:1 to an intervention group or control group. The intervention group will complete ePRO symptom severity scores on the PSA-Lung Scale questionnaire on discharge and post-discharge days 3, 7, 14, 21, 28. Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance. The control group will complete ePRO without clinician alerts. The primary outcome is rehabilitation exercise adherence rate over 1 month after discharge. Secondary outcomes include postoperative complications, hospital readmissions, symptom changes, exercise participation rate, and patient satisfaction. If proven effective, this innovative rehabilitation model can be scaled up to enhance recovery for more postoperative patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Neoplasms, Non-Small Cell Lung Cancer, Postoperative Complications, Patient Reported Outcome Measures, Telerehabilitation, Exercise Therapy
Keywords
Exercise Adherence, ePRO, Remote Monitoring, Postoperative Rehabilitation, Symptom Management

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
224 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
Participants randomized to the intervention group will complete ePRO symptom severity scores on the PSA-Lung questionnaire via the smartphone app on discharge and post-discharge days 3, 7, 14, 21, 28. Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Participants randomized to the control group will complete ePRO symptom severity scores on the PSA-Lung questionnaire via the smartphone app on discharge and post-discharge days 3, 7, 14, 21, 28, without clinician alerts.
Intervention Type
Procedure
Intervention Name(s)
ePRO based Remote Symptom Management
Other Intervention Name(s)
Symptom Management
Intervention Description
Alerts are triggered if any of 5 core symptoms scored ≥4, prompting remote clinician feedback and guidance on symptom management.
Primary Outcome Measure Information:
Title
Rehabilitation exercise adherence rate over 1 month after discharge
Description
Rehabilitation exercise adherence rate over 1 month after discharge, defined as the proportion of patients completing the prescribed outpatient exercise regimen.
Time Frame
From the day of discharge to 30 days after discharge
Secondary Outcome Measure Information:
Title
Post-discharge pulmonary complication rate
Time Frame
From the day of discharge to 30 days after discharge
Title
30-day hospital readmission rate
Time Frame
From the day of discharge to 30 days after discharge
Title
Changes in symptom severity scores from discharge to 30 days
Time Frame
From the day of discharge to 30 days after discharge
Title
Patient satisfaction scores
Time Frame
From the day of discharge to 30 days after discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18-75 years old Undergoing minimally invasive lung cancer resection Able to use smartphones and complete electronic questionnaires Signed informed consent Exclusion Criteria: ECOG score > 1 Received neoadjuvant therapy Previous lung resection surgery Unable to exercise due to physical limitations Continuous systemic corticosteroid use within 1 month before enrollment Unresolved toxicity above Grade 1 from previous treatments Significant comorbidities or medical history
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xiaojuan Yang
Phone
+86 0760-88823566
Email
1002381745@qq.com
Facility Information:
Facility Name
No.2 Sunwen East Rd.
City
Zhongshan
State/Province
Guangdong
ZIP/Postal Code
528403
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xiaojuan Yang
Phone
+86 0760-88823566
Email
1002381745@qq.com

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Not available. The individual participant data collected in this study will not be shared with external researchers.

Learn more about this trial

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

We'll reach out to this number within 24 hrs